Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.

Gaida MM, Haag N, Günther F, Tschaharganeh DF, Schirmacher P, Friess H, Giese NA, Schmidt J, Wente MN.

Int J Mol Med. 2010 Aug;26(2):281-8.

PMID:
20596609
2.
3.

Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.

Woods N, Trevino J, Coppola D, Chellappan S, Yang S, Padmanabhan J.

Oncotarget. 2015 Nov 3;6(34):35931-48. doi: 10.18632/oncotarget.5933.

4.

The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.

Doberstein K, Pfeilschifter J, Gutwein P.

Carcinogenesis. 2011 Nov;32(11):1713-23. doi: 10.1093/carcin/bgr195.

5.

Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.

Prox J, Willenbrock M, Weber S, Lehmann T, Schmidt-Arras D, Schwanbeck R, Saftig P, Schwake M.

Cell Mol Life Sci. 2012 Sep;69(17):2919-32. doi: 10.1007/s00018-012-0960-2.

PMID:
22446748
6.

Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.

Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW, Liu TY.

Cancer Lett. 2007 Jan 8;245(1-2):33-43.

PMID:
16309826
7.

ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.

Guo J, He L, Yuan P, Wang P, Lu Y, Tong F, Wang Y, Yin Y, Tian J, Sun J.

Oncol Rep. 2012 Nov;28(5):1709-18. doi: 10.3892/or.2012.2003.

PMID:
22940701
8.

A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.

Wojtalewicz N, Sadeqzadeh E, Weiß JV, Tehrani MM, Klein-Scory S, Hahn S, Schmiegel W, Warnken U, Schnölzer M, de Bock CE, Thorne RF, Schwarte-Waldhoff I.

PLoS One. 2014 Mar 13;9(3):e90461. doi: 10.1371/journal.pone.0090461.

9.

Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.

Xu Q, Liu X, Chen W, Zhang Z.

J Transl Med. 2010 Dec 20;8:136. doi: 10.1186/1479-5876-8-136.

10.

Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.

Kohga K, Takehara T, Tatsumi T, Miyagi T, Ishida H, Ohkawa K, Kanto T, Hiramatsu N, Hayashi N.

Cancer Res. 2009 Oct 15;69(20):8050-7. doi: 10.1158/0008-5472.CAN-09-0789.

11.

A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.

Zhang W, Liu S, Liu K, Wang Y, Ji B, Zhang X, Liu Y.

J Int Med Res. 2014 Jun;42(3):611-8. doi: 10.1177/0300060513505500.

PMID:
24670536
12.

Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.

Kai Y, Peng W, Ling W, Jiebing H, Zhuan B.

Biochem Biophys Res Commun. 2014 Jun 6;448(3):308-14. doi: 10.1016/j.bbrc.2014.02.032.

PMID:
24530397
13.

Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.

Riedle S, Kiefel H, Gast D, Bondong S, Wolterink S, Gutwein P, Altevogt P.

Biochem J. 2009 May 27;420(3):391-402. doi: 10.1042/BJ20081625.

14.
15.

Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.

Liu S, Zhang W, Liu K, Ji B, Wang G.

Mol Med Rep. 2015 Jan;11(1):597-602. doi: 10.3892/mmr.2014.2652.

PMID:
25323956
16.

Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.

Liu S, Zhang W, Liu K, Wang Y, Ji B, Liu Y.

Oncol Rep. 2014 Dec;32(6):2501-10. doi: 10.3892/or.2014.3503.

PMID:
25242535
17.

ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.

Fu L, Liu N, Han Y, Xie C, Li Q, Wang E.

Tumour Biol. 2014 Sep;35(9):9263-8. doi: 10.1007/s13277-014-2201-9.

PMID:
24935471
18.

ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.

Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, Reiss K.

Circ Res. 2008 May 23;102(10):1192-201. doi: 10.1161/CIRCRESAHA.107.169805.

19.

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

Lee SB, Schramme A, Doberstein K, Dummer R, Abdel-Bakky MS, Keller S, Altevogt P, Oh ST, Reichrath J, Oxmann D, Pfeilschifter J, Mihic-Probst D, Gutwein P.

J Invest Dermatol. 2010 Mar;130(3):763-73. doi: 10.1038/jid.2009.335.

20.

[miR-140-5p affects the migration and invasion of hypopharyngeal carcinoma cells by downregulating ADAM10 expression].

Jing P, Sa N, Xu W.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Mar;51(3):189-96. doi: 10.3760/cma.j.issn.1673-0860.2016.03.007. Chinese.

PMID:
27033573
Items per page

Supplemental Content

Support Center